Papers
15
Total Citations
1,131
H-Index
8
About
Jonathan Silberstein is a leading urologic oncologist whose research focuses on advancing surgical techniques for prostate, bladder, and kidney cancers. He is best known for his landmark 2014 randomized clinical trial comparing open radical cystectomy to robot-assisted laparoscopic radical cystectomy, which has garnered 596 citations and fundamentally shaped surgical decision-making for bladder cancer patients. Silberstein has pioneered the use of 3D-printed physical models of renal malignancies for individualized surgical simulation, with two highly cited studies (206 and 100 citations) demonstrating how these models improve preoperative planning and training. His work on prostate cancer includes a critical analysis of reverse stage shift at tertiary care centers (65 citations) and a case-mix-adjusted comparison of open versus robotic prostatectomy outcomes (47 citations). Silberstein has also contributed to improving surgical safety through the development of intraoperative crisis checklists for robotic surgery. His research consistently addresses disparities in care, including a study on racial differences in renal functional outcomes following robotic nephron-sparing surgery. With over 1,100 total citations across his most influential works, Silberstein’s contributions have directly enhanced surgical precision, patient safety, and equitable outcomes in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4Reverse stage shift at a tertiary care center65 citations · 2011
- 5
- 6
- 7
- 8
- 9Improving safety in robotic surgery: Intraoperative crisis checklist8 citations · 2013
- 10